- Home
- ZURA vs ZTEK Comparison
ZURA vs ZTEK Comparison
Compare ZURA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- ZTEK
- Stock Information
- Founded
- ZURA 2022
- ZTEK 2008
- Country
- ZURA United States
- ZTEK Canada
- Employees
- ZURA N/A
- ZTEK N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- ZTEK Major Chemicals
- Sector
- ZURA Health Care
- ZTEK Industrials
- Exchange
- ZURA Nasdaq
- ZTEK Nasdaq
- Market Cap
- ZURA 122.8M
- ZTEK 116.6M
- IPO Year
- ZURA N/A
- ZTEK N/A
- Fundamental
- Price
- ZURA $1.78
- ZTEK $1.15
- Analyst Decision
- ZURA Buy
- ZTEK
- Analyst Count
- ZURA 6
- ZTEK 0
- Target Price
- ZURA $15.80
- ZTEK N/A
- AVG Volume (30 Days)
- ZURA 514.2K
- ZTEK 54.6K
- Earning Date
- ZURA 03-12-2025
- ZTEK 02-11-2025
- Dividend Yield
- ZURA N/A
- ZTEK N/A
- EPS Growth
- ZURA N/A
- ZTEK N/A
- EPS
- ZURA N/A
- ZTEK N/A
- Revenue
- ZURA N/A
- ZTEK $29,132.00
- Revenue This Year
- ZURA N/A
- ZTEK N/A
- Revenue Next Year
- ZURA N/A
- ZTEK N/A
- P/E Ratio
- ZURA N/A
- ZTEK N/A
- Revenue Growth
- ZURA N/A
- ZTEK 8.15
- 52 Week Low
- ZURA $1.60
- ZTEK $0.50
- 52 Week High
- ZURA $6.35
- ZTEK $1.46
- Technical
- Relative Strength Index (RSI)
- ZURA 39.89
- ZTEK 56.69
- Support Level
- ZURA $1.71
- ZTEK $1.04
- Resistance Level
- ZURA $1.92
- ZTEK $1.17
- Average True Range (ATR)
- ZURA 0.14
- ZTEK 0.09
- MACD
- ZURA 0.03
- ZTEK 0.00
- Stochastic Oscillator
- ZURA 38.54
- ZTEK 80.26
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.